Skip to content
Search

Latest Stories

Number of UK coronavirus cases rises by 30% to 273, third person dies

The number of confirmed cases of coronavirus in the United Kingdom rose by 30 per cent to 273, the government said on Sunday, and a third person who tested positive for the virus has died.

The Department of Health and Social Care said the number of cases had risen by 64 from Saturday, the biggest one-day increase so far. The largest concentration of cases is in London, which has had 51.


England's Chief Medical Officer Chris Whitty said a third person had died in Britain after testing positive for the virus. The patient was over 60 years old, had "significant underlying health conditions" and had recently travelled from an affected area.

Prime Minister Boris Johnson will chair a meeting of the government's emergency committee on Monday.

"The number of coronavirus cases continues to rise in the UK and around the world," Johnson said. "We are well prepared and will continue to make decisions to protect the public based on the latest scientific advice."

The new coronavirus, which emerged in China in December, causes a disease called COVID-19. It has spread around the world, infecting more than 106,000 people and 3,600 people have died worldwide, according to a Reuters tally.

UK's emergency scientific group agreed last week that the virus was likely to spread in a significant way and the government will decide on Monday whether to move to the so called "delay phase" of its plan.

(Reuters)

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less